• GLAUCOMA

    Breakthrough Glaucoma Treatment Cleared By FDA For Patients

    Breakthrough Glaucoma Treatment Cleared By FDA: Millions of patients whose previous surgical Glaucoma Treatment failed to reduce their eye pressure have new hope following several years of pivotal clinical trials conducted in refractory glaucoma patients, including work done at the University of Southern California (USC) Roski Eye Institute, as Allergan announces the XEN® Glaucoma Treatment System has been approved by the U.S. Food and Drug Administration (FDA). Rohit Varma, MD, MPH, director of the USC Roski Eye Institute and dean of the Keck School of Medicine of USC, who led the work at USC, has called the XEN Glaucoma Treatment implantable device “a game changer” especially for those patients where refractory surgery treatments…